Sir Run Run Shaw Hospital
People's Republic of China
- Country
- People's Republic of China
- Ownership
- Private
- Established
- 1994-01-01
- Employees
- -
- Market Cap
- -
Total Neoadjuvant Therapy With Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Ultra Low Rectal Adenocarcinoma
- First Posted Date
- 2023-05-15
- Last Posted Date
- 2023-05-15
- Lead Sponsor
- Sir Run Run Shaw Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT05858567
- Locations
- 🇨🇳
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Efficacy and Neuroimaging Mechanisms of Smoking Cessation in China
Not Applicable
Completed
- Conditions
- Cigarette SmokingSmoking CessationPsychological Interventions
- Interventions
- Behavioral: Cognitive behavior therapy
- First Posted Date
- 2023-03-28
- Last Posted Date
- 2023-08-24
- Lead Sponsor
- Sir Run Run Shaw Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT05788068
- Locations
- 🇨🇳
Yanhui Liao, Hanzhou, Zhejiang, China
Prospective Clinical Cohort Study of Depression
- Conditions
- Major Depressive Disorder
- Interventions
- First Posted Date
- 2023-03-20
- Last Posted Date
- 2023-10-27
- Lead Sponsor
- Sir Run Run Shaw Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT05775809
- Locations
- 🇨🇳
Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China
Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma
Phase 3
Recruiting
- Conditions
- Rectal Cancer
- Interventions
- Biological: Envafolimab
- First Posted Date
- 2023-03-02
- Last Posted Date
- 2023-05-08
- Lead Sponsor
- Sir Run Run Shaw Hospital
- Target Recruit Count
- 108
- Registration Number
- NCT05752136
- Locations
- 🇨🇳
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Application Study of Infusing Irritant Medications Through Midline Catheter Based on Real World Study
Recruiting
- Conditions
- Catheter Complications
- First Posted Date
- 2023-02-02
- Last Posted Date
- 2023-02-02
- Lead Sponsor
- Sir Run Run Shaw Hospital
- Target Recruit Count
- 1500
- Registration Number
- NCT05710835
- Locations
- 🇨🇳
Linfang Zhao, Hangzhou, Zhejiang, China
Effect of Nicotine Transdermal Patch on Cognitive Function and Glycolipid Metabolism in Non-smoking Schizophrenia
- First Posted Date
- 2022-03-31
- Last Posted Date
- 2022-03-31
- Lead Sponsor
- Sir Run Run Shaw Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT05301660
Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma (PRECAM)
Phase 2
Completed
- Conditions
- MSS Locally Advanced Rectal Adenocarcinoma
- Interventions
- Radiation: Short-course RadiationProcedure: TME surgery, total mesorectal excision
- First Posted Date
- 2022-01-31
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Sir Run Run Shaw Hospital
- Target Recruit Count
- 32
- Registration Number
- NCT05216653
- Locations
- 🇨🇳
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
The Treatment of Bioartificial Liver With hiHep Cells After Extensive Hepatectomy
Early Phase 1
Recruiting
- Conditions
- Hepatoma Resectable
- Interventions
- Biological: hiHep bioartificial liver therapy
- First Posted Date
- 2021-09-05
- Last Posted Date
- 2025-04-13
- Lead Sponsor
- Sir Run Run Shaw Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT05035108
- Locations
- 🇨🇳
Department of General Surgery, Institute of Minimally Invasive Surgery, Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China
Carbapenem-resistant Organisms (CRO) Screening From Rectal Swabs in Patients With Hematological Diseases in China
- Conditions
- Carbapenem-resistant Acinetobacter BaumanniiHematological DiseasesCarbapenem-resistant EnterobacteriaceaeCarbapenem-resistant Pseudomonas Aeruginosa
- First Posted Date
- 2021-08-12
- Last Posted Date
- 2021-08-12
- Lead Sponsor
- Sir Run Run Shaw Hospital
- Target Recruit Count
- 5000
- Registration Number
- NCT05002582
- Locations
- 🇨🇳
Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China
Clinical Study of a Personalized Neoantigen Cancer Vaccine Combined With Anti-PD-1 and RFA in Patients With Solid Tumors
Phase 1
Recruiting
- Conditions
- Advanced Malignant Solid Tumor
- Interventions
- Biological: iNeo-Vac-P01Other: GM-CSFDrug: PD-1Procedure: RFA
- First Posted Date
- 2021-04-28
- Last Posted Date
- 2021-04-28
- Lead Sponsor
- Sir Run Run Shaw Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT04864379
- Locations
- 🇨🇳
Run Run Shaw Hospital Affiliated to Zhejiang University School of Medicine, Hangzhou, Zhejiang, China